Aletho News

The Machine

An Essay on the American Vaccine Program from License to Prosecution

Lies are Unbekoming | July 3, 2026

On November 14, 1986, Ronald Reagan signed the National Childhood Vaccine Injury Act into law.¹ The legislation ended more than a decade of tort litigation against vaccine manufacturers by transferring civil liability for injury and death from the companies producing the products to the American taxpayer. The pharmaceutical industry had threatened to leave the childhood vaccine market. Reagan’s signature ensured they would stay, at a price paid by parents who would never be told what had been arranged on their behalf.

Twenty-five years later, in Bruesewitz v. Wyeth, the Supreme Court closed the last remaining exit. The 2011 decision, written by Justice Antonin Scalia, held that federal law preempts all design-defect claims against vaccine manufacturers in state courts.² Justice Sotomayor’s dissent, joined by Justice Ginsburg, identified the practical effect: no federal agency, no state court, no jury of citizens would henceforth ensure that vaccine manufacturers accounted for scientific advances when designing their products. The manufacturers had been placed outside the accountability structure that governs every other industry in the United States.

The 1986 Act and the 2011 ruling together defined the shape of what now exists. Every function of the vaccine program — licensing, recommendation, purchase, safety monitoring, patent holding, research funding, injury adjudication, and courtroom defense — resides in the federal government. When the products kill a child, the state prosecutes the parents.

Leslie Manookian, founder of the Health Freedom Defense Fund, mapped this architecture in a twelve-point summary published to her readers.³ What follows walks through the machine she described, in five stages. Each stage encloses the next. By the fifth, the shape of the trap around the American parent becomes fully visible.

In January 2018, attorney Aaron Siri deposed Dr. Stanley Plotkin in New Hope, Pennsylvania — the vaccinologist widely regarded as the industry’s founding figure and co-editor of the standard reference textbook Plotkin’s Vaccines.⁴ Under oath, Siri walked Plotkin through the pre-licensure clinical trials for each product on the recommended childhood schedule. The pattern that emerged was uniform.

The safety review period following each dose was 48 hours for the IPOL polio vaccine. 48 hours for ActHIB. Four days for Engerix-B, the hepatitis B vaccine administered to newborns on their first day of life. Five days for Recombivax HB, the other hepatitis B product. Siri produced, for comparison, the package insert for Enbrel — a drug given to adults with rheumatoid arthritis — and asked Plotkin to confirm that its pre-licensure clinical trials monitored patients for up to 80 months. Plotkin confirmed. A drug given to sick adults was studied for six and a half years. Vaccines given to healthy newborns were studied for 48 hours to five days.

Plotkin then confirmed, product by product, that these trials had no saline placebo control group. Not Recombivax HB. Not Engerix-B. Not IPOL, whose trial subjects received the polio vaccine concurrently with DTP, making it impossible to attribute any reaction to either product. Not ActHIB. The MMR II vaccine, which Plotkin himself was present for the licensure of, had, in his own words, no control group “for the studies that I’m recalling.” When the Hiberix Hib vaccine was later licensed, the manufacturer used ActHIB itself as the “placebo” — testing one Hib vaccine against another.

On the necessity of a saline control, Plotkin was direct: “Without a control group, if you’re looking for a phenomenon occurring in the vaccine group, you cannot judge that phenomenon without having a control group.” That is the industry’s founding figure, testifying under oath, describing the epistemic condition of the products his industry markets.

The pattern in the trials produces a specific consequence. When a new vaccine is tested against an existing licensed vaccine as its control, any injury rate common to both groups becomes invisible. The comparison measures relative difference, not absolute harm. If the existing vaccine produces seizures at a rate of 1 in 500, and the new vaccine produces seizures at a rate of 1 in 500, the trial reports no significant difference — and both products remain on the market.

The Gardasil trial illustrates what happens when a saline group is included but the result is inconvenient. Merck’s pre-licensure clinical trial for its HPV vaccine assigned 9,412 subjects to a “placebo” arm. Of these, only 594 received actual saline. The remaining approximately 8,800 received AAHS — the aluminum-containing adjuvant used in the Gardasil formulation itself. Merck reported the two groups combined, showing 2.3% of the “placebo” arm developing what the trial recorded as systemic autoimmune events, matched by 2.3% in the Gardasil arm. The vaccine was declared safe on the strength of no difference.

Siri produced the underlying trial data. Broken out separately, the saline placebo group of 594 girls and women showed zero such events. The aluminum group showed approximately 2.5%. Merck had recorded the difference and reported the combination.

Plotkin was asked why the two groups had been combined for that analysis when they were broken out separately for local reaction analysis on the preceding pages. His response, verbatim: “So going into the study, they just assumed aluminum wouldn’t cause autoimmunity and so that’s how they proceed in designing it.” A pre-licensure trial for a product administered to schoolgirls declared the vaccine safe by defining the aluminum adjuvant as inert, then combining subjects receiving that adjuvant with subjects receiving nothing.

Once a vaccine reaches the schedule, the failure to test it against saline becomes permanent. For each product Siri walked Plotkin through, he asked whether a proper placebo-controlled study could now be conducted. Plotkin confirmed, product by product, that it could not — running such a trial would be “unethical” in children whose vaccines are already recommended. The absence of a control group at the point of licensure becomes the reason no control group can ever be introduced. The regulatory record is locked at the point of the initial deception.

When a Freedom of Information Act request submitted by the Informed Consent Action Network in 2018 asked the Department of Health and Human Services to produce the biennial vaccine safety reports required by Section 300aa-27 of the 1986 Act, HHS was forced to respond that it had not produced a single such report in the thirty-two years since Reagan signed the law.⁵ The statutory obligation to review safety had been ignored for the entire life of the program.

The FDA license then triggers the second function. The Centers for Disease Control and Prevention convenes the Advisory Committee on Immunization Practices, which votes on whether to add the newly licensed vaccine to the recommended childhood schedule. ACIP members are drawn from the same institutional networks that developed and defended the products. Once added, the vaccine appears on the schedule that is distributed to every state health department in the country. The recommendation is not a mandate. It becomes one at the next stage.

Under oath in the same deposition, Plotkin acknowledged that he had served as medical and scientific director of Sanofi Pasteur in the 1990s, that he operated a personal consulting entity called Vaxconsult, and that he had received payments over the preceding two decades from Merck, GSK, Pfizer, Sanofi, and, in his own phrasing, “essentially all of the major manufacturers.” He had also consulted for the FDA. The industry’s founding figure had confirmed the case against the products his industry markets. He was also paid by every major manufacturer of those products.

Plotkin Under Oath: Nine Hours That Exposed the Vaccine Industry

2. The Mandate

The federal government does not directly mandate childhood vaccines. That function is delegated to the states.

Every state in the union has passed legislation requiring specified vaccines for school attendance. The specific list varies. The mechanism is uniform. Parents who wish to enroll their children in public school — and in many states private school — must produce documentation that their children have received the vaccines on the state’s list. The state list is drawn from the CDC schedule; the CDC schedule from the ACIP recommendation; the ACIP recommendation from the FDA license. The FDA license rests on trials that were never controlled against a genuine placebo.

The chain is complete before the parent enters the pediatrician’s office.

Under the Vaccines for Children program, established in 1993, the federal government purchases half of all childhood vaccines administered in the United States. Recent VFC spending has exceeded $5 billion annually.⁶ The federal government is the largest single purchaser of the products it licenses, the products it recommends, and the products the states mandate.

This creates a market structure without parallel elsewhere in American pharmaceutical policy. The maker of a blood pressure medication faces market discipline. Doctors may prescribe it or not, patients may fill the prescription or not, insurance may cover it or not. The maker of a childhood vaccine faces no equivalent constraint. The state compels administration; the federal government guarantees a buyer; demand is legislated. Revenue is secured before a single dose is delivered.

The mandate has hardened as it has aged. Every state at some point permitted medical, religious, and in some cases philosophical exemptions from the vaccine schedule. Over the past decade, state legislatures have moved to close them. California eliminated its personal belief exemption in 2015 through SB 277 following the Disneyland measles cluster. In 2019, New York eliminated its religious exemption; Maine followed the same year. Connecticut eliminated its religious exemption in 2021. The pattern has been consistent: a highly publicised incident, a legislative response drafted with industry input, and the removal of the exit ramp. The federal government does not need to mandate. The state legislatures have been prevailed upon to do it, and to progressively narrow the terms under which the mandate can be refused.

Leslie Manookian, in the interview she gave me,¹⁹ described the shape of what has been built here. “When we succeed and thrive outside the extant medical paradigm, we pose an existential threat to the medical complex which is why the main actors fight our information, experiences, and independence so fervently.” The compelled purchase is what makes the mandate machinery operate. Without it, the products would compete on their merits. With it, they do not compete at all.

Interview with Leslie Manookian

3. The Shield

The 1986 Act shielded manufacturers from every category of liability that governs other industries. The immunity covered injuries caused by design choices themselves — the composition of the product, the adjuvants used, the decisions about testing. A safer alternative product could exist and the manufacturer could refuse to adopt it, and the injured child’s family could not sue.

Justice Scalia’s opinion in Bruesewitz addressed a case brought by Robalee Bruesewitz on behalf of her daughter Hannah, who had suffered residual seizure disorder and developmental delay after receiving the DPT vaccine manufactured by Wyeth. The Bruesewitz family had exhausted the Vaccine Injury Compensation Program. They then attempted to sue Wyeth in state court, arguing that a safer alternative vaccine design existed and Wyeth had refused to adopt it. The Supreme Court held that federal law preempts such claims. The manufacturer’s choice to continue producing a design that injured children could not be litigated.

Sotomayor’s dissent identified the consequence. Vaccine manufacturers now occupy a regulatory space in which no external mechanism — regulatory agency, court, or jury — holds them accountable for design decisions. This is not an inference. It is a description of the legal structure the majority created.

Behind the shield sits a further conflict. The Department of Health and Human Services — the parent agency of the FDA, the CDC, the National Institutes of Health, and the Health Resources and Services Administration that runs the injury compensation program — holds patents on multiple childhood vaccines. HHS scientists Douglas Lowy and John Schiller developed the recombinant protein technology underlying Merck’s Gardasil and receive royalties on its sale.⁷ Similar patent and royalty arrangements extend to other products in the childhood schedule. The regulator collects revenue on the products it approves.

The research infrastructure that would produce independent safety findings is subject to a parallel capture. Studies funded by the CDC, the NIH, or by the manufacturers themselves consistently produce findings favorable to the schedule. The vaccinated-versus-unvaccinated comparison studies that would settle the fundamental question about long-term outcomes have not been funded. When independent researchers attempt them — Anthony Mawson’s 2017 study of homeschooled populations,⁸ Paul Thomas’s cohort analysis of his own pediatric practice⁹ — the results are attacked, retracted, or ignored, and the researchers face professional consequences.

The capture extends inside the agencies themselves. In August 2014, Dr. William Thompson, a senior epidemiologist at the CDC and co-author of the 2004 DeStefano study widely cited to reject any link between the MMR product and neurodevelopmental injury, submitted a statement through his attorney acknowledging that he and his co-authors had “omitted statistically significant information” from the published paper and had disposed of documents to conceal the omission.¹⁰ The withheld data showed an elevated risk of neurodevelopmental injury among African American boys who received the injection before thirty-six months of age. Thompson’s disclosure was made under whistleblower protection. Congress has never subpoenaed him to testify. The DeStefano paper remains uncorrected.

Merck faced a parallel qui tam action from two of its own virologists, Stephen Krahling and Joan Wlochowski, who alleged in a federal filing that Merck had falsified mumps vaccine efficacy data submitted to the FDA over the course of a decade.¹¹ The case, filed in 2010, moved slowly through the courts. The Department of Justice declined to intervene. Merck retained its exclusive contract to supply mumps vaccine to the U.S. government. The plaintiffs’ allegations of test manipulation entered the public record and produced no regulatory action.

The shield is a network. Liability preemption from Congress protects the manufacturer. Patent revenue aligns the regulator with the products it approves. Captured research funding directs the studies that might identify harm away from the questions that would find it. Judicial preemption then blocks any citizen who attempts to litigate the design decisions the products embody. Each layer supports the others. The whole structure is invisible to the parent standing in a pediatrician’s office being told the shot is safe.

No Liability, No Studies, No Accountability: The Vaccine System Aaron Siri Exposed in Federal Court

4. The Monitor Becomes the Promoter

The Centers for Disease Control and Prevention operates the Vaccine Adverse Event Reporting System. It also runs the promotional campaigns that place vaccination on the pediatric schedule. The agency responsible for detecting harm from the products is the same agency responsible for driving their uptake.

The conflict is not theoretical. Harvard Pilgrim Health Care, under a grant from the Agency for Healthcare Research and Quality within HHS, conducted an internal study of VAERS reporting rates in a Massachusetts patient population between 2007 and 2010. The study found that fewer than 1% of vaccine adverse events were being captured by the reporting system.¹² When the researchers attempted to communicate their findings to the CDC in order to develop improved reporting mechanisms, the agency stopped responding to their emails. The grant ended. The improved reporting system was never built.

The passive reporting infrastructure that captures under 1% of injuries then becomes the basis for the CDC’s public assurances that adverse events are rare.

The injury table itself has been subject to steady contraction. When the Vaccine Injury Compensation Program began in 1988, the injury table included a broader range of conditions presumed to be caused by vaccination, with corresponding timelines within which onset would qualify a case for compensation.¹³ Over the following decades, categories were removed or narrowed. Sudden Infant Death Syndrome, initially compensable when it followed vaccination within a specified window, was removed. Neurodevelopmental injury, briefly acknowledged as a category during the 1990s when concerns about the MMR product and other injections emerged, was removed. The seizure timelines were narrowed. Encephalopathy definitions were tightened.

The 1995 amendment illustrates the pattern. Residual seizure disorder — a category under which many families of children who had suffered seizures after DPT vaccination had successfully claimed compensation — was removed. Encephalopathy criteria were revised in ways that made the diagnosis nearly impossible to satisfy. The Advisory Commission on Childhood Vaccines, which recommended the changes, drew a majority of its membership from the same medical-institutional networks that administered and defended the vaccine schedule. Petitioners whose cases had been filed under the earlier table found themselves adjudicated under the new one. Cases that would have succeeded were denied.

Each removal reduced the number of compensable claims. The fund benefited. So did the manufacturers whose products would otherwise be more clearly implicated in the injury pattern.

The Institute of Medicine, tasked periodically with reviewing whether specific vaccines cause specific injuries, has repeatedly concluded that the evidence is insufficient to accept or reject a causal relationship for a majority of the injury-outcome pairs it examines.¹⁴ This finding — insufficient evidence — is then used in the injury compensation courtroom to deny claims. The absence of evidence functions as evidence of absence, produced by the very research infrastructure that would have to fund the studies to end the insufficiency.

The industry’s founding figure confirmed the position under oath in the same deposition. Asked directly whether he could make the scientific statement that childhood vaccines do not cause autism, Plotkin answered: “As a scientist, I would say that I do not have evidence one way or the other.” The IOM had found no study establishing that the DTaP or Tdap products do not cause autism. Plotkin acknowledged that no such study existed and that he personally held no evidence to support the claim his industry has spent three decades making.

The parent whose child seized within twelve hours of vaccination, developed encephalopathy, and never recovered enters a system that was prepared for her arrival. The injury table’s timeline for seizure onset has been shortened past the point where her child’s case qualifies. The IOM has declared the evidence insufficient. VAERS captured her report and did nothing with it. The monitor was never separate from the promoter.

5. The Court and the Blame

The Vaccine Injury Compensation Program is administered by the U.S. Court of Federal Claims. It is not a court in the ordinary sense. The proceedings involve no juries, no meaningful discovery, and no Article III judges — no judges appointed for life under the constitutional protections designed to insulate the judiciary from executive influence.

Cases are heard by “Special Masters,” Article I officers appointed by the Chief Judge of the Court of Federal Claims to seven-year terms. The Special Masters are drawn from a pool of attorneys with prior government experience. The Department of Justice provides the attorneys who defend against injury claims. HRSA administers the fund. The petitioner’s attorneys are paid from the same fund out of which awards are made.

Every party in the courtroom — the judge, the government’s defense attorneys, the fund itself, and the petitioner’s legal counsel — is paid by the federal government. The injured child’s family stands before a tribunal in which no independent party has an interest in a finding of injury.

The statistics reflect the structure. The majority of petitions filed with the VICP have been dismissed rather than compensated over the life of the program.¹⁵ Of the cases that succeed, the majority are settled rather than adjudicated on the merits, with no admission that the vaccine caused the injury. The compensation cap for a vaccine-caused death — $250,000 — has not been raised since the statute was passed in 1986.

The excise tax that funds the program is $0.75 per antigen per dose. The fund now holds over $4 billion.¹⁶ The families whose children were injured cannot access it through the ordinary legal system because the ordinary legal system has been closed to them.

This is the structure Leslie Manookian described in her twelve-point summary. Her exact phrasing on the final function is worth returning to: “So, parents who’ve already suffered an unimaginable tragedy are up against a govt court staffed by govt paid special masters and attorneys with no due process defending a govt licensed and govt mandated product for which they blame the victims for harm.”

The final phrase — “they blame the victims for harm” — describes the twelfth function of the machine. When a child collapses after vaccination with the sudden onset of retinal hemorrhages, subdural hematoma, and cerebral edema — the triad — the diagnosis assigned in emergency departments and coroner’s offices is “shaken baby syndrome” or its rebranded successor, “abusive head trauma.” The triad is presumed diagnostic of parental abuse. The parents are arrested.

The vaccine reaction that produces the identical triad — through encephalopathy, elevated intracranial pressure, and hemorrhagic events following injection — is not considered in the differential diagnosis.¹⁷ The diagnostic criteria for “shaken baby syndrome” were developed without accounting for it. The emergency physician, the coroner, and the child protective services investigator have all been trained within an institutional framework in which vaccine injury of this magnitude does not exist.

Alan Yurko’s ten-week-old son died in November 1997 shortly after receiving a round of childhood vaccinations. Yurko was convicted of first-degree murder in 1999 on the basis of the triad diagnosis and sentenced to life plus ten years in Florida state prison. He was released in 2004 after independent medical review of the case demonstrated that the shaking diagnosis could not be sustained and post-conviction proceedings established alternative medical explanations for the child’s injuries.¹⁸ Yurko is one documented case. There are others. The precise number is unknown because the diagnostic framework prevents the question from being asked.

A parent whose child dies after vaccination faces a compound structure. The vaccine that caused the death is licensed by the federal government, recommended by the federal government, purchased by the federal government, and defended in the injury court by the federal government. The manufacturer is shielded from civil liability by federal statute and Supreme Court precedent. The injury table does not recognize the death as vaccine-caused. The state, meanwhile, has assigned the triad diagnosis and turned the case over to the district attorney. The parent must now prove — in a criminal court, against the state — that the child was not shaken.

The Vaccine Court (2014)

The Position

Robalee Bruesewitz spent nearly two decades in litigation on behalf of her daughter. The Supreme Court’s ruling denied her family relief and closed the door behind them for every family that would come after. The 1986 Act had shifted liability from the manufacturer to the taxpayer. Bruesewitz confirmed that the shift was permanent and that no design decision made by the manufacturer could be challenged in any court open to ordinary Americans.

This is the position in which the American parent now stands. Her child’s pediatric visit will produce a recommendation to administer products licensed on the basis of trials that were never controlled against saline. The state will require their administration for school attendance. When injury results, over 99% of adverse events never reach VAERS at all, and the reports that do reach it change nothing. A family that attempts compensation will petition a court in which every party is paid by the federal government to defend the products or administer the fund. And when death occurs with the triad present, the emergency department’s diagnostic framework will not include vaccine reaction in the differential, and the parent enters the criminal jurisdiction as the presumed cause of the child’s death.

There is no exemption from this structure that carries no cost. State legislatures have progressively narrowed medical and religious exemptions; declining vaccines removes a child from school; injury bars a family from ordinary civil courts. And when death is accompanied by the triad, the state prosecutes the parent for the death.

Leslie Manookian described this arrangement, at the close of her twelve-point post, as “crony capitalism at best and pure evil fascism at worst.” The characterization is precise. A private industry produces the product. The state compels its administration, indemnifies the manufacturer against claims of harm, and prosecutes the parent when the harm arrives.

The machine’s design serves the flow of money and the concentration of power. Every safeguard the ordinary citizen might rely on — informed consent, product liability, judicial review, jury trial, prosecutorial restraint — has been removed at the point where the childhood vaccine schedule intersects with the American family. The parent who accepts the recommendation and whose child is injured has no meaningful path to redress. Refusal costs school access. Death with the triad opens the parent to criminal prosecution for a killing they did not commit.

This is the environment in which every American child is now born. The machine was assembled piece by piece across four decades, ratified by every institution that could have prevented it, and defended by the same institutions today. What Leslie Manookian named as crony capitalism at best and fascism at worst describes a working system, operating as designed, in a country that once organised its politics around the presumption that no such system could be permitted to form.

For a Six-Year-Old

There is a big company that makes shots.

The government helps the company make the shots and sell them. The government tells your school that you have to get the shots before you can come to school.

Nobody checks the shots very well. The people who are supposed to check work with the company. So the shots go out into the world before anyone really knows if they are safe.

When a child is hurt by a shot, the family cannot go to a normal judge. There is a special room where a different kind of judge decides. That judge is paid by the government. The lawyers on the other side are paid by the government. The government made the shot rules. The government bought the shots. And the government decides whether the shot hurt you.

Most families are told the shot did not hurt their child, even when it did.

When a shot makes a baby die, the doctors sometimes think the mother or father shook the baby. The parents can be arrested. They can go to prison. For what the shot did.

The company that made the shot never gets in trouble. The company keeps making the shots. Your school keeps requiring them. The next family goes through the same door.

That is the machine.

---

References

¹ National Childhood Vaccine Injury Act of 1986, Public Law 99-660, 42 U.S.C. § 300aa-1 et seq.

² Bruesewitz v. Wyeth LLC, 562 U.S. 223 (2011).

³ Leslie Manookian, twelve-point summary post, X (@LeslieManookian), July 3, 2026, status/2072712451800625369.

⁴ Deposition of Stanley A. Plotkin, M.D., taken January 11, 2018, in Matheson v. Schmitt, State of Michigan, Circuit Court for the County of Oakland, Family Division, Case No. 2015-831539-DM; transcript published via Informed Consent Action Network.

⁵ ICAN v. HHS, correspondence dated July 9, 2018, in response to FOIA request; HHS acknowledged no biennial reports produced under 42 U.S.C. § 300aa-27(c).

⁶ Vaccines for Children Program expenditure data, Centers for Disease Control and Prevention; annual VFC purchasing figures.

⁷ U.S. Patents 5,437,951 and related — Lowy, Schiller et al., “Self-Assembling Recombinant Papillomavirus Capsid Proteins,” assigned to the United States Department of Health and Human Services; licensed to Merck & Co. for Gardasil.

⁸ Mawson AR et al., “Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12-year-old U.S. children,” Journal of Translational Science, 2017.

⁹ Thomas JL, Lyons-Weiler J, “Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses Along the Axis of Vaccination,” International Journal of Environmental Research and Public Health, 2020.

¹⁰ Statement of William W. Thompson, Ph.D., through counsel Rick Morgan, August 27, 2014; documentation regarding DeStefano DA et al., “Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan Atlanta,” Pediatrics, 2004.

¹¹ United States ex rel. Krahling and Wlochowski v. Merck & Co., Inc., No. 2:10-cv-04374, U.S. District Court for the Eastern District of Pennsylvania, complaint filed 2010.

¹² Lazarus R et al., “Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP:VAERS),” Grant Final Report, Harvard Pilgrim Health Care, Inc., 2011 (AHRQ Grant ID R18 HS 017045).

¹³ Vaccine Injury Table history, Health Resources and Services Administration; successive amendments to 42 C.F.R. § 100.3.

¹⁴ Institute of Medicine (now the National Academy of Medicine), Adverse Effects of Vaccines: Evidence and Causality (2011) and predecessor reports.

¹⁵ Health Resources and Services Administration, VICP claim adjudication statistics.

¹⁶ Vaccine Injury Compensation Trust Fund monthly balance report, U.S. Department of the Treasury.

¹⁷ Michael Innis, “Vaccines, Apparent Life-Threatening Events, Barlow’s Disease, and Questions about ‘Shaken Baby Syndrome,’” Journal of American Physicians and Surgeons, 2006; Harold Buttram and Alan R. Yurko, “Shaken Baby Syndrome or Vaccine-Induced Encephalitis?” Medical Sentinel, subsequent case documentation.

¹⁸ State of Florida v. Alan R. Yurko, Ninth Judicial Circuit, 1999; post-conviction proceedings and release 2004; contemporaneous medical review including Harold E. Buttram, M.D.

¹⁹ Unbekoming, “Interview with Leslie Manookian, Health Freedom Defense Fund,” Lies are Unbekoming, Substack, April 13, 2024.

July 4, 2026 - Posted by aletho | Corruption, Deception, Progressive Hypocrite, Science and Pseudo-Science, Timeless or most popular